近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

WONG PS, ROBERTS RE and RANDALL MD, 2015. Hyperoxic gassing with Tiron enhances bradykinin-induced endothelium-dependent and EDH-type relaxation through generation of hydrogen peroxide. Pharmacological research : the official journal of the Italian Pharmacological Society. 91, 29-35 WONG, PUI SAN, ROBERTS, RICHARD E. and RANDALL, MICHAEL D., 2015. Sex differences in the role of transient receptor potential (TRP) channels in endothelium-dependent vasorelaxation in porcine isolated coronary arteries EUROPEAN JOURNAL OF PHARMACOLOGY. 750, 108-117 WONG, PUI SAN, RANDALL, MICHAEL D. and ROBERTS, RICHARD E., 2015. Sex differences in the role of NADPH oxidases in endothelium-dependent vasorelaxation in porcine isolated coronary arteries VASCULAR PHARMACOLOGY. 72, 83-92 WHEAL AJ, CIPRIANO M, FOWLER CJ, RANDALL MD and O'SULLIVAN SE, 2014. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation. The Journal of pharmacology and experimental therapeutics. 351(2), 457-66 WONG PS, GARLE MJ, ALEXANDER SPH, RANDALL MD and ROBERTS RE, 2014. A role for the sodium pump in H2O2-induced vasorelaxation in porcine isolated coronary arteries. Pharmacological research : the official journal of the Italian Pharmacological Society. 90, 25-35 WONG PS, ROBERTS RE and RANDALL MD, 2014. Sex differences in endothelial function in porcine coronary arteries: a role for H2O2 and gap junctions? British journal of pharmacology. 171(11), 2751-66 WHEAL, A.J., ALEXANDER, S.P.H. and RANDALL, M.D., 2012. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries European Journal Of Pharmacology. 674(2-3), 384-390 HOPPS, J.J., DUNN, W.R. and RANDALL, M.D., 2012. Vasorelaxation to capsaicin and its effects on calcium influx in arteries. European Journal of Pharmacology. 681, 88-93 RANDALL, M.D., KENDALL, D.A. and ALEXANDER, S.P.H., 2012. Fast Track Pharmacology Second edition. HOPPS, J.J., DUNN, W.R. and RANDALL, M.D., 2012. Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension. European Journal of Pharmacology. 684, 102-107 WHEAL, A.J., ALEXANDER, S.P.H. and RANDALL, M.D., 2010. Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity British Journal of Pharmacology. 160(3), 701-711 TEP-AREENAN, P., INGKANINAN, K. and RANDALL, M.D., 2010. Mechanisms of Kaempferia parviflora extract (KPE)-induced vasorelaxation in the rat aorta Asian Biomedicine. 4, 103-111 O'SULLIVAN SE, KENDALL DA, RANDALL MD., 2009. Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma). PPAR Research. Volume 2009, 425289 WHEAL, A.J. and RANDALL, M.D., 2009. Effects of hypertension on vasorelaxation to endocannabinoids in vitro European Journal of Pharmacology. 603(1-3), 79-85 O'SULLIVAN, S.E., SUN, Y., BENNETT, A.J., RANDALL, M.D. and KENDALL, D.A., 2009. Time-dependent vascular actions of cannabidiol in the rat aorta European Journal of Pharmacology. 612(1-3), 61-68 RANDALL, M.D. and NEIL, K.E., 2009. Disease Management: A guide to clinical pharmacology Second edition. Pharmaceutical Press. RANDALL, M.D., KENDALL, D.A. and ALEXANDER, S.P.H., 2009. Fast Track Pharmacology First edition. Pharmaceutical Press. HO, W-S.V., BARRETT, D.A. and RANDALL, M.D., 2008. ‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors British Journal of Pharmacology. 155(6), 837-846 RANDALL, MICHAEL D, KENDALL, DAVID A, BENNETT, ANDREW J and O'SULLIVAN, SAOIRSE E, 2007. Rimonabant in obese patients with type 2 diabetes. Lancet. 369(9561), 555 ALEXANDER, S P H and RANDALL, M, 2007. Cannabinoids and their actions. British Journal of Pharmacology. 152(5), 557-8 O'SULLIVAN, S.E., RANDALL, M.D. and GARDINER, S.M, 2007. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase. Journal of Pharmacology and Experimental Therapeutics. 321(2), 663-672 WHEAL, A J, BENNETT, T, RANDALL, M D and GARDINER, S M, 2007. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. British Journal of Pharmacology. 152(5), 717-24 WHEAL, A J, BENNETT, T, RANDALL, M D and GARDINER, S M, 2007. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. British Journal of Pharmacology. 150(5), 662-71 HO, W-S V and RANDALL, M D, 2007. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. British Journal of Pharmacology. 150(5), 641-51 RANDALL, M D, 2007. Endocannabinoids and the haematological system. British Journal of Pharmacology. 152(5), 671-5